Premium
Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
Author(s) -
JiménezJiménez F. J.,
Hernánz A.,
MedinaAcebrón S.,
De Bustos F.,
Zurdo J. M.,
Alonso H.,
Puertas I.,
Barcenilla B.,
Sayed Y.,
CabreraValdivia F.
Publication year - 2005
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.2005.00370.x
Subject(s) - amyotrophic lateral sclerosis , cerebrospinal fluid , tau protein , degenerative disease , medicine , pathology , multiple sclerosis , central nervous system disease , disease , alzheimer's disease , immunology
Objective – To elucidate whether cerebrospinal fluid (CSF) concentrations of the microtubule‐associated tau protein are related to the risk for sporadic amyotrophic lateral sclerosis (SALS). Patients/Methods – We measured tau concentrations in the CSF of 18 patients with SALS and 75 age‐ and sex‐matched controls, using a specific ELISA method. Results – The mean CSF concentrations of tau protein did not differ significantly between SALS patient and control groups, were not influenced by the clinical form (spinal vs bulbar) of ALS, and were not correlated with age, age at onset, and duration of the disease. Conclusions – CSF tau concentrations are not a biochemical marker of ALS.